Cingulate CING
NASDAQ CING
$4.57 +0.04 (+0.89%)
As of: Oct 21, 2026 · 10:49 AM EDT

Cingulate (CING) EPS (Basic) (2021 - 2026)

Updated

Cingulate (CING) recorded EPS (Basic) of -$0.45 in Q2 2026, compared with -$1.14 a year earlier.

Analysis

Cingulate (CING) EPS (Basic) (2021 - 2026) Analysis & Trends

On a TTM basis, Cingulate's EPS (Basic) came in at -$1.86 as of Jun 30, 2026; for FY2025, it came in at -$4.44.

  • Across earlier years, EPS (Basic) came in at -$10.86 in FY2024, -$312.00 in FY2023, -$375.12 in FY2022 and -$670.46 in FY2021.
  • The Q2 2026 figure is the highest quarterly EPS (Basic) in data going back to Q4 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Eli Lilly 1,132.34 Bn 1,100.93 Bn 19.71 Bn 7.95
2 Johnson & Johnson 615.91 Bn 534.44 Bn 17.26 Bn 2.30
3 AbbVie 505.47 Bn 478.59 Bn 12.70 Bn 2.04
4 Merck 368.25 Bn 322.63 Bn 12.21 Bn -0.54
5 Novartis Ag 298.18 Bn 262.17 Bn 11.24 Bn 1.68
6 Astrazeneca 261.66 Bn 235.34 Bn 12.86 Bn 1.62
7 Amgen 236.22 Bn 191.62 Bn 7.24 Bn 4.40
8 Gilead Sciences 190.68 Bn 164.87 Bn 6.22 Bn -8.44
9 Pfizer 170.14 Bn 116.79 Bn 10.94 Bn -0.04
10 Cingulate 60.52 Mn 5.53 Mn - -0.45
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -0.45
Dec 31, 2025 -1.24
Sep 30, 2025 -1.35
Jun 30, 2025 -1.14
Mar 31, 2025 -1.06
Dec 31, 2024 -4.09
Sep 30, 2024 -2.34
Jun 30, 2024 -5.51
Mar 31, 2024 -7.21
Dec 31, 2023 -91.93
Sep 30, 2023 -72.60
Jun 30, 2023 -135.79
Mar 31, 2023 -84.99
Dec 31, 2022 -97.73
Sep 30, 2022 -85.47
Jun 30, 2022 -85.75
Mar 31, 2022 -106.18
Dec 31, 2021 -85.91
API Access

Cingulate EPS (Basic) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=eps-basic&ticker=CING&period=max&api_key=YOUR_API_KEY